GlassScriptPhysician profile
Nirupama Krishnamurthi
NPI 1225597123
$11,593.02
in general payments reported to CMS, 2019-2025
26 companies · $9,762 in 2025
The $9,762 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $59.82 · 2023: $468 · 2024: $1,304 · 2025: $9,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,401 · Food and Beverage: $5,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,401.20 |
| Food and Beverage | $5,132.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,839.85 | 2025 | Prostar, Gallant, Ensite Precision |
| Biosense Webster, INC. | $2,450.85 | 2025 | Carto 3 |
| Medtronic, INC. | $2,311.10 | 2023-2025 | Corevalve Evolut R, Micra, Advisa Dr Mri Surescan |
| Abiomed | $917.19 | 2024-2025 | Impella |
| Boston Scientific Corporation | $479.51 | 2025 | Ekosonic, Avvigo Guidance System, Watchman |
| Actelion Pharmaceuticals US, INC. | $295.94 | 2024-2025 | Opsumit, Uptravi |
| Angiodynamics, INC. | $197.29 | 2024 | Alphavac |
| Novartis Pharmaceuticals Corporation | $177.52 | 2024-2025 | |
| Inari Medical, INC. | $175.73 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $113.84 | 2023-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $86.01 | 2024-2025 | |
| Bridgebio Pharma, INC. | $79.08 | 2025 | Attruby |
| Pfizer INC. | $77.91 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.97 | 2022-2024 | Jardiance |
| Cardiva Medical, INC. | $50.96 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $36.07 | 2024-2025 | Wainua |
| Kiniksa Pharmaceuticals International, Plc | $32.56 | 2024 | Arcalyst |
| Cvrx, INC. | $28.38 | 2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $27.94 | 2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $27.35 | 2023 | Inpefa |
| Merck Sharp & Dohme LLC | $23.45 | 2023 | Verquvo |
| Contego Medical, INC | $18.50 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.21 | 2025 | Lifevest |
| Lilly USA, LLC | $17.84 | 2022 | |
| Shockwave Medical, INC | $17.13 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $15.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirupama Krishnamurthi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.